U.S. flag

An official website of the United States government

NM_024818.6(UBA5):c.813G>C (p.Lys271Asn) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 6, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000825648.4

Allele description [Variation Report for NM_024818.6(UBA5):c.813G>C (p.Lys271Asn)]

NM_024818.6(UBA5):c.813G>C (p.Lys271Asn)

Genes:
NPHP3-ACAD11:NPHP3-ACAD11 readthrough (NMD candidate) [Gene - HGNC]
UBA5:ubiquitin like modifier activating enzyme 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q22.1
Genomic location:
Preferred name:
NM_024818.6(UBA5):c.813G>C (p.Lys271Asn)
HGVS:
  • NC_000003.12:g.132675248G>C
  • NG_052968.1:g.25803G>C
  • NM_001320210.2:c.645G>C
  • NM_001321238.2:c.543G>C
  • NM_001321239.1:c.477G>C
  • NM_024818.6:c.813G>CMANE SELECT
  • NM_198329.4:c.645G>C
  • NP_001307139.1:p.Lys215Asn
  • NP_001308167.1:p.Lys181Asn
  • NP_001308168.1:p.Lys159Asn
  • NP_079094.1:p.Lys271Asn
  • NP_938143.1:p.Lys215Asn
  • NC_000003.11:g.132394092G>C
  • NM_024818.3:c.813G>C
  • p.Lys271Asn
Protein change:
K159N
Links:
dbSNP: rs1576652827
NCBI 1000 Genomes Browser:
rs1576652827
Molecular consequence:
  • NM_001320210.2:c.645G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001321238.2:c.543G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001321239.1:c.477G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_024818.6:c.813G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198329.4:c.645G>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000967018Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(Dec 6, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided21not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000967018.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (1)

Description

The p.Lys271Asn variant in UBA5 has not been previously reported in individuals with disease or in large population studies. The variant was detected in trans w ith a pathogenic hypomorphic variant (p.Ala371Thr) in this patient with infantil e spasms, intractable epilepsy, microcephaly, cortical vision impairment, and gl obal developmental delays with regression. Computational prediction tools and am ino acid conservation analysis suggest that the p.Lys271Asn variant may impact t he protein, though this information is not predictive enough to determine pathog enicity through a protein sequence change. This variant is located in the first base of the exon, which is part of the 3? splice region, making a splicing impac t possible; however, this position is not highly conserved such that a predicted impact to splicing is unclear. In summary, the clinical significance of the p.L ys271Asn variant is uncertain by ACMG/AMP criteria. ACMG/AMP Criteria applied: P M3, PM2, PP3.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided2not provided1not provided

Last Updated: Dec 24, 2022